Subcutaneous implantable cardioverter-defibrillator (S-ICD)

Cardiology Journal

Volumn 18, Issue 3, 2011, Pages 326-331

  Lobodzinski Suave, S ^a  

^a CALIFORNIA STATE UNIVERSITY   (United States)

Author keywords

Implantable cardioverter defibrillator; Subcutaneous implantation ventricular arrythmias; Subcutaneous lead electrode

Indexed keywords

ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; DEFIBRILLATOR; FLUOROSCOPY; HEART DEATH; HEART PACING; HEART RHYTHM; HEART VENTRICLE ARRHYTHMIA; HUMAN; PATIENT SELECTION; POSTOPERATIVE COMPLICATION; PRIMARY PREVENTION; PULSE GENERATOR; QRS COMPLEX; SURGICAL TECHNIQUE; T WAVE;

DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; DEVICE APPROVAL; ELECTRODES, IMPLANTED; EUROPE; HUMANS; PROSTHESIS DESIGN; PROSTHESIS IMPLANTATION; RISK FACTORS; TACHYCARDIA, VENTRICULAR;

EID: 79959324099     PISSN: 18975593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Mirowski M, Mower MM, Staewen WS et al. Standby automatic defibrillator: An approach to prevention of sudden coronary death. Arch Intern Med, 1970; 126: 158-161.
2. Schuder JC et al. Transthoracic ventricular defibrillation. In: The dog with truncated and untruncated exponential stimuli. IEEE Transactions on Bio-Medical Engineering, 1971; 18: 410-415.
3. Schuder JC. The role of an engineering oriented medical research group in developing improved methods and devices for achieving ventricular defibrillation: The University of Missouri experience. Pacing Clin Electrophysiol, 1993;16: 95-124.
4. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med, 1997; 337: 1576-1583.
5. Moss AJ, Zareba W, Hall WJ et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med, 2002; 346: 877-883.
6. Epstein AE, DiMarco JP, Ellenbogen KA et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities. J Am Coll Cardiol, 2008; 51: e1-e62.
7. Brady GH, Smith WM, Hood MA et al. An entirely subcutaneous implantable cardioverter-defibrillator. N Engl J Med, 2010; 363: 36-44.
8. www.clinicaltrials.gov, trial NCT01117792.
9. Theuns DMAJ, Abkenari JD, Jordaens L. Initial clinical experience with a novel, totally subcutaneous implantable defibrillator (S-ICD) system. ECS Stockholm, 01-09-2010.
10. www.clinicaltrials.gov, trial NCT01064076.
11. Dabiri Abkenari L, Theuns DA, Valk SD et al. Clinical experience with a novel subcutaneous implantable defibrillator system in a single center. Clin Res Cardiol, 2011; 17: [Epub ahead of print].
12. Dabiri Abkenari L, Nordkamp LO, Boersma L et al. The subcutaneous defibrillator: The Dutch experience. Heart Rhythm Society 2011 Scientific Sessions; May 4, 2011; San Francisco, CA.